UB Paderborn / Katalog / Suche / in CDI

1 – 13 von 13

Sortiert nach

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4574-4580

2011

Volltextzugriff (PDF)

Standardization of HER2 testing: results of an international proficiency-testing ring study

Modern pathology, 2007-05, Vol.20 (5), p.584-591

2007

Volltextzugriff (PDF)

An apparent clinical pharmacokinetic drug–drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism

Cancer chemotherapy and pharmacology, 2017-04, Vol.79 (4), p.661-671

2017

Volltextzugriff (PDF)

A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors

Clinical cancer research, 2010-04, Vol.16 (8), p.2458-2465

2010

Volltextzugriff (PDF)

Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2015-07, Vol.17 (7), p.1007-1015

2015

Volltextzugriff (PDF)

Abstract 4719: Exploratory biomarker program in Phase I clinical development of RG7155, a novel humanized anti-CSF-1R Mab, targeting Tumor Associated Macrophages (TAMs)

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4719-4719

2013

Volltextzugriff (PDF)

Phase I study of anti-PlGF monoclonal antibody (mAb) RO5323441 (RO) and anti-VEGF mab bevacizumab (BV) in patients with recurrent glioblastoma (GBM)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2092-2092

2013

Volltextzugriff (PDF)

Synthesis of an unsaturated fatty acid analogue (18-(4'-azido-2'-hydroxybenzoylamino)-oleic acid) and its interaction with lysophosphatidylcholine: acyl-CoA-O-acyltransferase

Journal of lipid research, 1998-05, Vol.39 (5), p.1118-1126

1998

Volltextzugriff (PDF)

Solubilization, partial purification and photolabeling of the integral membrane protein lysophospholipid:acyl‐CoA acyltransferase (LAT)

European journal of biochemistry, 2000-11, Vol.267 (21), p.6339-6345

2000

Volltextzugriff (PDF)

Substrate Specificity of Acyl-CoA:Lysophospholipid Acyltransferase (LAT) from Pig Spleen

Archives of biochemistry and biophysics, 1998-03, Vol.351 (2), p.220-226

1998

Volltextzugriff (PDF)

The Mitogen-Induced Lysophospholipid:acyl-CoA Acyltransferase (LAT) Expression in Human T-Lymphocytes Is Diminished by Hydrocortisone

Biochemical and biophysical research communications, 1997-08, Vol.237 (3), p.632-638

1997

Volltextzugriff (PDF)

Identification of two different lysophosphatidylcholine:acyl-CoA acyltransferases (LAT) in pig spleen with putative distinct topological localization

Biochimica et biophysica acta, 1996-08, Vol.1302 (3), p.249-256

1996

Volltextzugriff (PDF)

Manufacturing of a wear detecting sensor made of 17-4PH steel using standard wafer processing technology

Sensors and actuators. A. Physical., 2011-11, Vol.171 (1), p.34-37

2011

Volltextzugriff (PDF)

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(13)

Sprache

Englisch
(13)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung Cancer

Standardization of HER2 testing: results of an international proficiency-testing ring study

An apparent clinical pharmacokinetic drug–drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism

A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors

Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma

Abstract 4719: Exploratory biomarker program in Phase I clinical development of RG7155, a novel humanized anti-CSF-1R Mab, targeting Tumor Associated Macrophages (TAMs)

Phase I study of anti-PlGF monoclonal antibody (mAb) RO5323441 (RO) and anti-VEGF mab bevacizumab (BV) in patients with recurrent glioblastoma (GBM)

Synthesis of an unsaturated fatty acid analogue (18-(4'-azido-2'-hydroxybenzoylamino)-oleic acid) and its interaction with lysophosphatidylcholine: acyl-CoA-O-acyltransferase

Solubilization, partial purification and photolabeling of the integral membrane protein lysophospholipid:acyl‐CoA acyltransferase (LAT)

Substrate Specificity of Acyl-CoA:Lysophospholipid Acyltransferase (LAT) from Pig Spleen

The Mitogen-Induced Lysophospholipid:acyl-CoA Acyltransferase (LAT) Expression in Human T-Lymphocytes Is Diminished by Hydrocortisone

Identification of two different lysophosphatidylcholine:acyl-CoA acyltransferases (LAT) in pig spleen with putative distinct topological localization

Manufacturing of a wear detecting sensor made of 17-4PH steel using standard wafer processing technology

Suchergebnisse filtern